Department of surgical-oncology - KMC | Manipal Academy of Higher Education

Department of Surgical Oncology, KMC Manipal

About the Department

The Department of Surgical Oncology, Kasturba Medical College was established in 1992 and was one of the earliest Surgical Oncology departments in this part of the state. The department has grown strength to strength, abreast with latest developments and moving towards the goal of adequate cancer surgery along with function/organ preservation in tune with the internationally accepted treatment standards and guidelines. It is an internationally acclaimed centre for cancer treatment and research, catering to the needs of people of the state of Karnataka and adjoining parts of Kerala and Goa. The department has several innovative and pioneering work in cancer control, treatment, research and training to its credit. The department provides a thorough surgical care, starting with establishing the diagnosis, through comprehensive staging of the tumour, oncologically sound surgery and a high standards of post-operative care. The department is located in the Shirdi Sai Baba Cancer Centre and Research block and is a part of Manipal Comprehensive Cancer Care Centre (MCCCC) with full-fledged departments of Radiation Oncology, Medical Oncology, Paediatric Oncology, Palliative Medicine and Nuclear Medicine and supported by allied services such as Plastic surgery, Critical care medicine, Anaesthesiology, Pathology, Radiology, Microbiology, Nutrition and Transfusion Medicine.

On an average, 750 major oncological surgeries are performed by the department in a year. The spectrum of surgeries includes basic, advanced and supra major complex resections and reconstructions. Routine operations include procedures for head and neck (including Thyroid and Salivary Gland tumors), breast and gynecological cancers (Ovary, Cervix and Endometrial cancers). Major procedures performed are all types of Esophageal cancer surgeries, Hepato-pancreatico-biliary cancer surgeries (Liver, Bile duct and Pancreatic tumors), upper and lower Gastrointestinal cancer surgeries (Stomach, Colon and Rectal Cancers), Thoracic cancer surgeries (Lung, Trachea, Mediastinal neoplasms Including Thymus gland tumor), Limb salvage surgery (Bone and soft tissue tumors), Hyper-thermic Intraperitoneal Chemotherapy (HIPEC) and Pelvic exenterations etc. Minimally invasive cancer surgeries include advanced laparoscopic and thoracoscopic (VATS-Video Assisted Thoracoscopic Surgery) surgeries.

Adjunct Faculty

Dr. Avanish Saklani

Professor, Robotic Surgery colorectal, Tata memorial Cancer Centre, Mumbai

Dr. Somashekhar S P

Consultant, Surgical Oncology

Manipal Hospital, Bangalore

Dr. Shabber S Zaveri

Consultant, Surgical Oncology

Manipal Hospital, Bangalore

Services Offered

Thoracoscopic (VATS) surgery – Esophageal cancer, Lung and Mediastinal tumors
Laparoscopic surgery- Stomach, Pancreas, Colorectal, Gynecological and Urological cancers
TAMIS- Trans-anal Minimally invasive surgery for early rectal cancers
Inter-sphincteric resection (ISR) – Sphincter preserving surgery for low rectal cancer
Conservative surgery- Breast, Limb saving surgery, Nephron sparing for kidney cancer
Sentinel node – Breast, Gynecological and Urological cancers
Cytoreductive surgery + Hyper-thermic Intra Peritoneal Chemotherapy (HIPEC) for Peritoneal surface malignancies, Stomach, Colorectal cancer, Ovarian cancer.
Pelvic Exenterative surgery – Colorectal, Gynec and Urological cancers
Lung and liver surgery/metastatectomy
Plastic reconstruction-Local and free flaps.
Chemotherapy venous access devices insertion

Publications

1. Kumar NA, Desouza A, Ostwal V, et al. Outcomes of exenteration in cT4 and fixed cT3 stage primary rectal adenocarcinoma: a subgroup analysis of consolidation chemotherapy following neoadjuvant concurrent chemoradiotherapy. Langenbecks Arch Surg. 2021 May;406(3):821-831. doi: 10.1007/s00423-021-02143-7. Epub 2021 Mar 17. PMID: 33733285.

2. Kumar NAN. Interpreting the RAPIDO trial: factors to consider. Lancet Oncol. 2021 Mar;22(3):e86. doi: 10.1016/S1470-2045(21)00011-5. PMID: 33662294.

3. Kumar NA, Sasi SP, Shinde RS, et al. Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer. JSLS. 2020;24(3):e2020.00026. doi:10.4293/JSLS.2020.00026

4. Kumar NA, Desouza A, Bhandare MS, et al. Curative resection for adenocarcinoma of the gastro-esophageal junction following neo-adjuvant chemotherapy-thoraco-abdominal vs. trans-abdominal approach. Langenbecks Arch Surg. 2021 May;406(3):613-621. doi: 10.1007/s00423-020-02020-9. Epub 2020 Nov 26. PMID: 33242137.

5. Jose A, Shenoy GG, Sunil Rodrigues G, Kumar NAN, Munisamy M, Thomas L, Kolesar J, Rai G, Rao PPN, Rao M. Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy. Cancers (Basel). 2020 Jul 31;12(8):2121. doi: 10.3390/cancers12082121. PMID: 32751840; PMCID: PMC7465382.

https://eprints.manipal.edu/view/subjects/SURO.html